Related Experiment Video
Updated: Jul 11, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 10, 2014
HIV integrase: a target for drug discovery.
1Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Genes and Function
|March 21, 2007
Summary
HIV integrase (IN) is a key target for new antiviral drugs. Structural analysis of IN domains provides a basis for developing novel HIV integrase inhibitors to combat drug resistance.
Area of Science:
- Structural Biology
- Antiviral Drug Discovery
- Molecular Virology
Background:
- Current HIV therapies target reverse transcriptase (RT) and protease (PR).
- HIV integrase (IN) is essential for viral replication and lacks host analogues, making it a promising drug target.
- IN functions by forming a complex with DNA and metal ions, utilizing a catalytic mechanism shared with polynucleotidyl transferases.
Purpose of the Study:
- To explore HIV integrase (IN) as a target for novel antiviral drug development.
- To leverage structural information of IN domains for rational drug design.
- To identify new classes of anti-HIV drugs beyond existing RT and PR inhibitors.
Main Methods:
- X-ray crystallography and NMR spectroscopy were employed to determine the structures of the three functional domains of HIV integrase.
- Structure-function analysis of identified HIV integrase inhibitors.
Main Results:
- Structures of the N-terminal (zinc-binding fold), catalytic (polynucleotidyl transferase motif), and C-terminal (Src-homology-3-like fold) domains of HIV IN were elucidated.
- This structural data provides a foundation for the development of IN-targeted therapeutics.
- A growing number of IN inhibitors are available for further structure-function studies.
Conclusions:
- Structural insights into HIV integrase domains are crucial for developing new anti-HIV medications.
- The development of novel HIV integrase inhibitors is a viable strategy to expand anti-HIV treatment options.
- These new drugs could complement existing anti-RT and anti-PR therapies.
More Related Videos
09:31Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
Published on: March 22, 2016
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...